Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ivonne Wobst"'
Autor:
Susanne Schiffmann, Jessica Sandner, Ronald Schmidt, Kerstin Birod, Ivonne Wobst, Helmut Schmidt, Carlo Angioni, Gerd Geisslinger, Sabine Grösch
Publikováno v:
Journal of Lipid Research, Vol 50, Iss 1, Pp 32-40 (2009)
Sphingolipids such as ceramides (Cers) play important roles in cell proliferation, apoptosis, and cell cycle regulation. An increased Cer level is linked to the cytotoxic effects of several chemotherapeutics. Various selective cyclooxygenase-2 (COX-2
Externí odkaz:
https://doaj.org/article/f5caba274d5f44caba4e7defd379fb55
Autor:
Heiko Zettl, Manfred Schubert-Zsilavecz, Florian Rörsch, Gisbert Schneider, Gerd Geisslinger, Ivonne Wobst, Sabine Grösch, Ewgenij Proschak
Publikováno v:
Journal of Medicinal Chemistry. 53:911-915
Microsomal prostaglandin E(2)-synthase (mPGES-1) is a target for future anti-inflammatory drugs. Inhibitors of mPGES-1 mimicking prostaglandin E(2) often interact with cyclooxygenases (COXs) 1 and 2, leading to unwanted side effects. Selective inhibi
Autor:
Clemens Glaubitz, Dieter Steinhilber, Susanne Schiffmann, Thorsten J. Maier, Sabine Grösch, Kerstin Birod, Gerd Geisslinger, Carlo Angioni, Ivonne Wobst, Jakob J. Lopez, Marika Hoffmann
Publikováno v:
Maier, T, Schiffmann, S, Wobst, I, Birod, K, Angioni, C, Hoffmann, M, Lopez, J J, Glaubitz, C, Steinhilber, D, Geisslinger, G & Grösch, S 2009, ' Cellular membranes function as a storage compartment for celecoxib ' Journal of Molecular Medicine, vol. 87, no. 10, pp. 981-93 . https://doi.org/10.1007/s00109-009-0506-8
Celecoxib is a selective cyclooxygenase-2-(COX-2)-inhibitor used to treat inflammation and pain and prevents colorectal cancer in patients at high doses by affecting several non-COX-2 proteins. However, celecoxib concentrations appropriate to inhibit
Autor:
Sabine Grösch, Carlo Angioni, Susanne Schiffmann, Kerstin Birod, Ronald Schmidt, Gerd Geisslinger, Helmut Schmidt, Ivonne Wobst, Jessica Sandner
Publikováno v:
Journal of Lipid Research, Vol 50, Iss 1, Pp 32-40 (2009)
Sphingolipids such as ceramides (Cers) play important roles in cell proliferation, apoptosis, and cell cycle regulation. An increased Cer level is linked to the cytotoxic effects of several chemotherapeutics. Various selective cyclooxygenase-2 (COX-2
Autor:
Susanne Schiffmann, Astrid Janssen, Carlo Angioni, Thorsten J. Maier, Sabine Grösch, Ivonne Wobst, Gerd Geisslinger, Heike Corban-Wilhelm
Publikováno v:
Schiffmann, S, Maier, T, Wobst, I, Janssen, A, Corban-Wilhelm, H, Angioni, C, Geisslinger, G & Grösch, S 2008, ' The anti-proliferative potency of celecoxib is not a class effect of coxibs ', Biochemical Pharmacology, vol. 76, no. 2, pp. 179-87 . https://doi.org/10.1016/j.bcp.2008.04.017
Celecoxib, a COX-2 (cyclooxygenase-2)-selective inhibitor (coxib), is the only NSAID (non-steroidal anti-inflammatory drug) that has been approved for adjuvant treatment of patients with familial adenomatous polyposis. To investigate if the anti-prol
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 41:1317-1324
Eicosanoids play an important role as lipid mediators for physiological and pathological processes. Inhibitors of their biosynthesis have been developed as drugs for various diseases with major health political relevance. The search for more efficien
Autor:
Eugen Ruckhäberle, Jörn Lötsch, Susanne Schiffmann, Ivonne Wobst, Gerd Geisslinger, Hanns Ackermann, Jessica Sandner, Sabine Grösch, Kerstin Birod, Helmut Schmidt, Manfred Kaufmann, Carlo Angioni
Publikováno v:
Carcinogenesis. 30(5)
Several in vitro studies have correlated dysfunction of the sphingolipid-signaling pathway with promotion of tumor cell growth as well as progression and resistance of tumors to chemotherapeutic agents. As ceramides (Cer) constitute the structural ba
Autor:
Carlo Angioni, Sabine Grösch, Ronald Schmidt, Ivonne Wobst, Susanne Schiffmann, Kerstin Birod, Thorsten J. Maier, Gerd Geisslinger
Publikováno v:
Wobst, I, Schiffmann, S, Birod, K, Maier, T, Schmidt, R, Angioni, C, Geisslinger, G & Grösch, S 2008, ' Dimethylcelecoxib inhibits prostaglandin E2 production ', Biochemical Pharmacology, vol. 76, no. 1, pp. 62-9 . https://doi.org/10.1016/j.bcp.2008.04.008
Dimethylcelecoxib (DMC), a derivative of celecoxib, has been developed to distinguish between the COX-dependent and COX-independent anti-carcinogenic effects of celecoxib. Although DMC has been shown to have no COX-inhibitory activity, it is importan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::108756e560a2b040e02b6f9e2735792b
https://pure.au.dk/portal/da/publications/dimethylcelecoxib-inhibits-prostaglandin-e2-production(e619632c-e99e-4f55-8398-8854d0347cf6).html
https://pure.au.dk/portal/da/publications/dimethylcelecoxib-inhibits-prostaglandin-e2-production(e619632c-e99e-4f55-8398-8854d0347cf6).html
Autor:
Astrid Janssen, Sabine Grösch, Susanne Schiffmann, Thorsten J. Maier, Kerstin Birod, Gerd Geisslinger, Ivonne Wobst
Publikováno v:
Janssen, A, Schiffmann, S, Birod, K, Maier, T, Wobst, I, Geisslinger, G & Grösch, S 2008, ' p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells ' Biochemical and Biophysical Research Communications, vol. 365, no. 4, pp. 698-703 . https://doi.org/10.1016/j.bbrc.2007.11.051
S-ibuprofen which inhibits the cyclooxygenase-1/-2 and R-ibuprofen which shows no COX-inhibition at therapeutic concentrations have anti-carcinogenic effects in human colon cancer cells; however, the molecular mechanisms for these effects are still u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c64873c83802e5901384ab1be6ea9d9
https://pure.au.dk/portal/da/publications/p53-is-important-for-the-antiproliferative-effect-of-ibuprofen-in-colon-carcinoma-cells(e3a669a8-e974-4b6a-a1f7-08612c4c0fff).html
https://pure.au.dk/portal/da/publications/p53-is-important-for-the-antiproliferative-effect-of-ibuprofen-in-colon-carcinoma-cells(e3a669a8-e974-4b6a-a1f7-08612c4c0fff).html
Autor:
Florian Rörsch, Ivonne Wobst, Heiko Zettl, Manfred Schubert-Zsilavecz, Sabine Grösch, Gerd Geisslinger, Gisbert Schneider, Ewgenij Proschak
Publikováno v:
Journal of Medicinal Chemistry; Jan2010, Vol. 53 Issue 2, p911-915, 5p